Notice for PF-07321332 and ritonavir (Pfizer Australia Pty Ltd)
Active ingredients
PF-07321332 and ritonavir
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Indication
For the treatment of adult patients with symptomatic, confirmed coronavirus infection
Therapeutic area
Infectious diseases